Ander beskermde aminosure vir disulfiedbinding
Produkbesonderhede
| NO | Produkte | CAS nee | Toepassing | Belangrike kwaliteit aanwyser | ||||
| Suiwerheid | Isomeer | Spesifieke onreinheid | *MAX1 | Vog | ||||
| 1 | FMOC-Cys (ACM) -OH | 86060-81-3 | Disulfiedbinding | ≥99,0% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
| 2 | FMOC-Cys (MMT) -OH | 177582-21-7 | Disulfiedbinding | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 3 | FMOC-Cys (4-allylbutyrate) -OH | / | Disulfiedbinding | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 4 | MPA (TRT) -OH | 27144-18-9 | Einde van die volgorde | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 5 | Fmoc-thr (tbu) -ol | 189337-28-8 | Oktreotied | ≥97,0% | ≤0,3% | ≤0,5% | ≤1,0% | ≤1,0% |
| 6 | FMOC-D-ARG (PBF) -OH | 187618-60-6 | Desmopressin | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤2,0% |
| 7 | Fmoc-Gly-Gly-OH | 35665-38-4 | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 8 | FMOC-GLY-GLY-GLY-OH | 170941-79-4 | Terlipressien | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 9 | FMOC-GLY-GLY-GLY-GLY-OH | / | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 10 | FMOC-Gly-Asp (TBU) -OH | / | Bivalirudin | ≥99,5% | / | ≤0,15% | ≤0,2% | ≤1,0% |
| 11 | BOC-CYS (TRT) -OH | 21947-98-8 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 12 | BOC-ARG (PBF) -OH | 200124-22-7 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 13 | Boc-ala-oh | 15761-38-3 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 14 | BOC-D-PHE-OH | 18942-49-9 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 15 | BOC-GLY-OH | 4530-20-5 | Einde van die volgorde | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 16 | BOC-Lys (BOC) -OH.DCHA | 15098-69-8 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 17 | BOC-SER (TBU) -OH | 7738-22-9 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 18 | Boc-thr (tbu) -OH | 13734-40-2 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 19 | BOC-D-ALA-OH | 7764-95-6 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 20 | BOC-met-oh | 2488-15-5 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 21 | BOC-TYR (TBU) -OH | 47375-34-8 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 22 | BOC-D-ARG (PDF) -OH | 187618-60-6 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 23 | BOC-ASP (OTBU) -OH.DCHA | 1913/12/8 | Einde van die volgorde | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 24 | FMOC-HOMOARG (PBF) -OH | 1159680-21-3 | Eptifibatide | ≥98,5% | ≤0,2% | / | ≤0,5% | ≤2,0% |
| 25 | FMOC-ASP-OTBU | 129460-09-9 | Timalfasien | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
| 26 | Fmoc-tyr (ek) -Oh | 77128-72-4 | Karbetosien | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 27 | FMOC-niere (BOC) -OH | 109425-55-0 | Atosiban Omnipressien Daptomycin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤2,0% |
| 28 | FMOC-D-TYR (ET) -OH | 162502-65-0 | Atosiban | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
| 29 | Fmoc-asp (oall) -OH | 146982-24-3 | Melanotan | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
| 31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamelanotide | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
| 32 | Ac-glu (otbu) -Oh | 84192-88-1 | Argireline Asetiel octapeptied-3 | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 33 | AC-ß-ALA-OH · DCHA | / | Asetiel tetrapeptied-5 | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
| 34 | FMOC-ß-ala-oh | 35737-10-1 | Asetiel tetrapeptied-5 | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
| 35 | FMOC-hyp (TBU) -OH | 122996-47-8 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 36 | Fmoc-thi-oh | 130309-35-2 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 37 | Fmoc-d-tic-oh | 130309-33-0 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 38 | Fmoc-oic-oh | 130309-37-4 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 39 | BOC-SAR-OH | 13734-36-6 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 40 | FMOC-SAR-OH | 77128-70-2 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 41 | FMOC-Tyr (SO3NA) -OH.H2O | 106864-37-3 | Mincalide | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 42 | FMOC-D-ASP (OTBU) -OH | 112883-39-3 | Daptomycin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 43 | AC-SER (TBU) -OH | 77285-09-7 | Afamelanotide | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
| 44 | BOC-HOMOCYS (TRT) -OH | 201419-16-1 | Depreotied | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 45 | FMOC-homocys (TRT) -OH | 167015-23-8 | Depreotied | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
| 46 | Fmoc-dab-oh | 161420-87-7 | Slanggif | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
*Max1 = maksimum onbekende suiwerheid
Ander aanwyser:
- asynsuur: ≤0,02% (alle produkte)
- Etielasetaat: ≤0,5% (alle produkte)
- Alkohol: ≤0,5% (alle produkte)
-Maksimum onbekende onreinheid: FMOC-TRP (BOC) -OH (143824-78-6) ≤0,3%; Ander ≤0,2%
